ERIS LIFESCIENCES
|
ERIS LIFESCIENCES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity - Authorised | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
Equity - Issued | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity Paid Up | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹5.01 Cr | ₹2.80 Cr | ₹1.90 Cr | ₹3.97 Cr | ₹2.85 Cr |
Total Reserves | ₹2,568 Cr | ₹2,180 Cr | ₹1,893 Cr | ₹1,559 Cr | ₹1,280 Cr |
Securities Premium | ₹18 Cr | ₹15 Cr | ₹11 Cr | - | - |
Capital Reserves | ₹8.38 Cr | ₹8.38 Cr | ₹8.38 Cr | ₹8.38 Cr | ₹8.38 Cr |
Profit & Loss Account Balance | ₹2,541 Cr | ₹2,156 Cr | ₹1,874 Cr | ₹1,550 Cr | ₹1,271 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.17 Cr | ₹0.17 Cr | ₹0.17 Cr | ₹0.17 Cr | ₹0.17 Cr |
Reserve excluding Revaluation Reserve | ₹2,568 Cr | ₹2,180 Cr | ₹1,893 Cr | ₹1,559 Cr | ₹1,280 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,586 Cr | ₹2,196 Cr | ₹1,908 Cr | ₹1,576 Cr | ₹1,296 Cr |
Minority Interest | ₹636 Cr | ₹25 Cr | ₹-0.11 Cr | ₹0.00 Cr | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹655 Cr | ₹644 Cr | ₹45 Cr | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹655 Cr | ₹644 Cr | ₹45 Cr | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹236 Cr | ₹-16 Cr | ₹-197 Cr | ₹-151 Cr | ₹-120 Cr |
Deferred Tax Assets | ₹491 Cr | ₹401 Cr | ₹360 Cr | ₹303 Cr | ₹249 Cr |
Deferred Tax Liability | ₹727 Cr | ₹384 Cr | ₹163 Cr | ₹152 Cr | ₹128 Cr |
Other Long Term Liabilities | ₹45 Cr | ₹57 Cr | ₹41 Cr | ₹11 Cr | ₹15 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹53 Cr | ₹45 Cr | ₹32 Cr | ₹31 Cr | ₹26 Cr |
Total Non-Current Liabilities | ₹988 Cr | ₹730 Cr | ₹-79 Cr | ₹-109 Cr | ₹-80 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹268 Cr | ₹125 Cr | ₹118 Cr | ₹103 Cr | ₹100 Cr |
Sundry Creditors | ₹268 Cr | ₹125 Cr | ₹118 Cr | ₹103 Cr | ₹100 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹851 Cr | ₹190 Cr | ₹36 Cr | ₹29 Cr | ₹27 Cr |
Bank Overdraft / Short term credit | - | ₹15 Cr | ₹9.26 Cr | ₹9.30 Cr | ₹0.84 Cr |
Advances received from customers | ₹21 Cr | ₹3.34 Cr | ₹3.87 Cr | ₹2.89 Cr | ₹2.48 Cr |
Interest Accrued But Not Due | ₹10 Cr | ₹2.74 Cr | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | ₹438 Cr | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹382 Cr | ₹169 Cr | ₹23 Cr | ₹17 Cr | ₹24 Cr |
Short Term Borrowings | ₹1,311 Cr | ₹55 Cr | ₹0.01 Cr | ₹0.01 Cr | - |
Secured ST Loans repayable on Demands | ₹330 Cr | ₹55 Cr | - | - | - |
Working Capital Loans- Sec | ₹330 Cr | ₹55 Cr | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹652 Cr | ₹-55 Cr | ₹0.01 Cr | ₹0.01 Cr | - |
Short Term Provisions | ₹179 Cr | ₹151 Cr | ₹130 Cr | ₹104 Cr | ₹93 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹116 Cr | ₹82 Cr | ₹91 Cr | ₹76 Cr | ₹62 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹62 Cr | ₹69 Cr | ₹39 Cr | ₹27 Cr | ₹30 Cr |
Total Current Liabilities | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr | ₹220 Cr |
Total Liabilities | ₹6,819 Cr | ₹3,472 Cr | ₹2,113 Cr | ₹1,703 Cr | ₹1,437 Cr |
ASSETS | |||||
Gross Block | ₹4,781 Cr | ₹2,843 Cr | ₹1,092 Cr | ₹1,006 Cr | ₹984 Cr |
Less: Accumulated Depreciation | ₹454 Cr | ₹275 Cr | ₹174 Cr | ₹152 Cr | ₹109 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹4,328 Cr | ₹2,568 Cr | ₹918 Cr | ₹854 Cr | ₹875 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹19 Cr | ₹21 Cr | ₹24 Cr | - | - |
Non Current Investments | ₹16 Cr | ₹6.69 Cr | ₹421 Cr | ₹244 Cr | ₹3.20 Cr |
Long Term Investment | ₹16 Cr | ₹6.69 Cr | ₹421 Cr | ₹244 Cr | ₹3.20 Cr |
Quoted | ₹5.33 Cr | ₹0.33 Cr | ₹0.35 Cr | ₹0.36 Cr | ₹0.34 Cr |
Unquoted | ₹10 Cr | ₹6.36 Cr | ₹420 Cr | ₹243 Cr | ₹2.86 Cr |
Long Term Loans & Advances | ₹70 Cr | ₹25 Cr | ₹36 Cr | ₹26 Cr | ₹16 Cr |
Other Non Current Assets | ₹7.43 Cr | ₹7.37 Cr | - | ₹42 Cr | ₹2.88 Cr |
Total Non-Current Assets | ₹4,440 Cr | ₹2,629 Cr | ₹1,402 Cr | ₹1,167 Cr | ₹902 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹0.00 Cr | ₹30 Cr | ₹100 Cr | ₹50 Cr | ₹75 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.00 Cr | ₹30 Cr | ₹100 Cr | ₹50 Cr | ₹75 Cr |
Inventories | ₹189 Cr | ₹131 Cr | ₹118 Cr | ₹94 Cr | ₹69 Cr |
Raw Materials | ₹65 Cr | ₹45 Cr | ₹39 Cr | ₹17 Cr | ₹30 Cr |
Work-in Progress | ₹11 Cr | ₹3.84 Cr | ₹1.98 Cr | ₹2.64 Cr | ₹3.28 Cr |
Finished Goods | ₹38 Cr | ₹20 Cr | ₹23 Cr | ₹25 Cr | ₹20 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹8.05 Cr | ₹0.96 Cr | ₹1.04 Cr | ₹0.29 Cr | ₹0.29 Cr |
Other Inventory | ₹68 Cr | ₹62 Cr | ₹53 Cr | ₹49 Cr | ₹16 Cr |
Sundry Debtors | ₹422 Cr | ₹293 Cr | ₹161 Cr | ₹140 Cr | ₹157 Cr |
Debtors more than Six months | ₹42 Cr | ₹6.57 Cr | ₹36 Cr | ₹4.91 Cr | - |
Debtors Others | ₹402 Cr | ₹290 Cr | ₹128 Cr | ₹139 Cr | ₹159 Cr |
Cash and Bank | ₹1,401 Cr | ₹58 Cr | ₹52 Cr | ₹38 Cr | ₹67 Cr |
Cash in hand | ₹0.25 Cr | ₹0.03 Cr | ₹0.12 Cr | ₹0.08 Cr | ₹0.07 Cr |
Balances at Bank | ₹1,393 Cr | ₹58 Cr | ₹42 Cr | ₹33 Cr | ₹66 Cr |
Other cash and bank balances | ₹6.97 Cr | - | ₹11 Cr | ₹5.07 Cr | ₹1.19 Cr |
Other Current Assets | ₹31 Cr | ₹22 Cr | ₹24 Cr | ₹36 Cr | ₹55 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.08 Cr | ₹0.06 Cr | ₹1.83 Cr | ₹0.76 Cr | ₹0.01 Cr |
Prepaid Expenses | ₹26 Cr | ₹17 Cr | ₹21 Cr | ₹7.99 Cr | ₹7.48 Cr |
Other current_assets | ₹5.59 Cr | ₹5.07 Cr | ₹0.77 Cr | ₹27 Cr | ₹48 Cr |
Short Term Loans and Advances | ₹336 Cr | ₹308 Cr | ₹256 Cr | ₹176 Cr | ₹111 Cr |
Advances recoverable in cash or in kind | ₹115 Cr | ₹69 Cr | ₹62 Cr | ₹58 Cr | ₹51 Cr |
Advance income tax and TDS | ₹77 Cr | ₹78 Cr | ₹84 Cr | ₹69 Cr | ₹55 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹144 Cr | ₹161 Cr | ₹110 Cr | ₹50 Cr | ₹5.48 Cr |
Total Current Assets | ₹2,379 Cr | ₹843 Cr | ₹711 Cr | ₹536 Cr | ₹535 Cr |
Net Current Assets (Including Current Investments) | ₹-230 Cr | ₹321 Cr | ₹428 Cr | ₹300 Cr | ₹315 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹6,819 Cr | ₹3,472 Cr | ₹2,113 Cr | ₹1,703 Cr | ₹1,437 Cr |
Contingent Liabilities | ₹30 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr | ₹17 Cr |
Total Debt | ₹2,735 Cr | ₹830 Cr | ₹45 Cr | ₹0.01 Cr | - |
Book Value | 189.75 | 161.28 | 140.25 | 115.81 | 95.26 |
Adjusted Book Value | 189.75 | 161.28 | 140.25 | 115.81 | 95.26 |
Compare Balance Sheet of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹18,729.4 Cr | 1.7% | 7.8% | 46.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 1.7% |
7.8% |
46.5% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses